We are live on ! Find out more
ILI

INTERLEUKIN GENETICS INC
ILI

Delisted

ILI was delisted on the 13th of August, 2010.

Back to rankings

1 hedge funds and large institutions have $69K invested in INTERLEUKIN GENETICS INC in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CL
CPWM LLC
Washington
+$69K

Top Sellers

No sellers this quarter

ILI Hedge Fund Activity: Q1 2017 in Review

1 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in INTERLEUKIN GENETICS INC (ILI) for Q1 2017, worth a combined $69K.

Buyers outnumbered sellers: 1 fund opened new ILI positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was CPWM LLC, opening a new position worth an estimated $69K.

  • 1 institutional investor held INTERLEUKIN GENETICS INC (ILI) as of Q1 2017, up from 0 in Q4 2016.
  • Funds reported $69K of INTERLEUKIN GENETICS INC stock for Q1 2017.
  • 1 fund opened new INTERLEUKIN GENETICS INC positions in Q1 2017 and 0 closed out, a net change of +1 holder.
  • The largest INTERLEUKIN GENETICS INC buyer in Q1 2017 was CPWM LLC, an estimated $69K added.

Based on aggregated 13F filings for Q1 2017.